Variables | Univariate (OS) | |
---|---|---|
HR (95%CI) | P value | |
histology | ||
AC | 1.00 (reference) | |
SCC | 1.02 (0.93–1.12) | 0.69 |
age (%) | ||
< 40 | 1.00 (reference) | |
40–49 | 1.03 (0.93–1.13) | 0.61 |
50–59 | 0.97 (0.88–1.08) | 0.59 |
60–69 | 1.01 (0.90–1.14) | 0.81 |
race (%) | ||
Black | 1.00 (reference) | |
White | 1.06 (0.95–1.18) | 0.28 |
Other | 1.20 (1.03–1.39) | 0.02 |
grade (%) | ||
I | 1.00 (reference) | |
II | 1.07 (0.93–1.24) | 0.36 |
III | 1.00 (0.86–1.15) | 0.95 |
IV | 1.12 (0.82–1.53) | 0.47 |
FIGO stage (%) | ||
Ib2 | 1.00 (reference) | |
IIa1 | 1.02 (0.81–1.27) | 0.88 |
IIa2 | 1.17 (0.96–1.43) | 0.12 |
IIb | 0.98 (0.87–1.10) | 0.72 |
IIIa | 1.07 (0.80–1.42) | 0.64 |
IIIb | 1.00 (0.90–1.11) | 0.94 |
IVa | 0.74 (0.57–0.98) | 0.03 |
sequence (%) | ||
No surgery | 1.00 (reference) | |
RPTS | 0.88 (0.73–1.05) | 0.16 |
RAS | 0.93 (0.87–1.01) | 0.10 |
RBAS | 1.11 (0.72–1.73) | 0.63 |
Radiation (%) | ||
Beam radiation | 1.00 (reference) | |
brachytherapy | 0.98 (0.86–1.11) | 0.70 |
BRB | 0.93 (0.86–1.00) | 0.06 |
Chemotherapy | ||
Yes | 1.00 (reference) | |
No | 0.85 (0.75–0.97) | 0.01 |